Secor Alicia 4
4 · ZEVRA THERAPEUTICS, INC. · Filed Dec 9, 2025
Insider Transaction Report
Form 4
Secor Alicia
Director
Transactions
- Award
Stock Option (right to buy)
2025-12-02+45,000→ 45,000 totalExercise: $8.17Exp: 2035-12-01→ Common Stock (45,000 underlying)
Footnotes (2)
- [F1]The exercise price is equal to the closing price of the Issuer's common stock on the Nasdaq Global Select Market on the date of grant, December 2, 2025.
- [F2]The option will vest and become exercisable as follows: (1) in three equal installments on the each of the dates that are one day prior to the first three annual stockholder meetings occurring after the grant date, or (2) immediately prior to a Change in Control, subject in each case to the director's continued service on such vesting date.